Old Web
English
Sign In
Acemap
>
authorDetail
>
Cahya Nova Ardiyatno
Cahya Nova Ardiyatno
Nuclear Energy Agency
Nimotuzumab
DOTA
Medicine
Epidermal growth factor receptor
Molecular biology
4
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Fragmentation of Nimotuzumab for Preparation of 125I-F(ab')2-Nimotuzumab as a Precursor for Preparing 125I-F(ab')2-Nimotuzumab-NLS Radiopharmaceutical for Cancer Therapy
2014
R.D. Haryuni
A. Bahtiar
S. Soenarjo
Y. Harahap
Abdul Mutalib
Martalena Ramli
S. Hermanto
Cahya Nova Ardiyatno
Veronika Yulianti Susilo
D. Haffid
Show All
Source
Cite
Save
Citations (0)
Fragmentation of Nimotuzumab for Preparation of 125 I-F(ab') 2 -Nimotuzumab as a Precursor for Preparing 125 I-F(ab') 2 -Nimotuzumab-NLS Radiopharmaceutical for Cancer Therapy
2014
R.D. Haryuni
A. Bahtiar
S. Soenarjo
Y. Harahap
Abdul Mutalib
Martalena Ramli
S. Hermanto
Cahya Nova Ardiyatno
Veronika Yulianti Susilo
D. Haffid
Show All
Source
Cite
Save
Citations (1)
Preclinical Study of 177Lu-DOTA-Trastuzumab: A Potential Radiopharmaceutical for Therapy of Breast Cancer Positive HER-2
2013
Martalena Ramli
Basuki Hidayat
Sri Aguswarini
Karyadi Karyadi
Cahya Nova Ardiyatno
Hammad Subur
Titis Sekar Humani
Rien Ritawidya
Abdul Mutalib
Johan S. Masjhur
Show All
Source
Cite
Save
Citations (1)
In Vitro and In Vivo Testing of 177Lu-DOTA-Nimotuzumab, a Potential Radioimmunotherapeutical Agent of Cancers
2012
Martalena Ramli
Basuki Hidayat
Cecep Taufik Rustendi
Muhammad Subur
Cahya Nova Ardiyatno
Karyadi Karyadi
Sri Aguswarini
Titis Sekar Humani
Rien Ritawidya
Abdul Mutalib
Johan S. Masjhur
Show All
Source
Cite
Save
Citations (4)
1